4//SEC Filing
Wenstrup Richard 4
Accession 0001437749-17-013099
CIK 0001586049other
Filed
Jul 25, 8:00 PM ET
Accepted
Jul 26, 4:30 PM ET
Size
6.6 KB
Accession
0001437749-17-013099
Insider Transaction Report
Form 4
Wenstrup Richard
Chief Medical Officer
Transactions
- Award
Ordinary Shares
2017-07-24+18,622→ 18,622 total - Award
Share Option (Right to Buy)
2017-07-24+61,920→ 61,920 totalExercise: $16.11Exp: 2027-07-24→ Ordinary Shares (61,920 underlying)
Footnotes (2)
- [F1]Option granted under Issuer's 2013 Share Incentive Plan.
- [F2]Options will become exercisable ratably on the anniversary of the vesting start date from August 1, 2018 through August 1, 2021.
Documents
Issuer
Oxford Immunotec Global PLC
CIK 0001586049
Entity typeother
Related Parties
1- filerCIK 0001645683
Filing Metadata
- Form type
- 4
- Filed
- Jul 25, 8:00 PM ET
- Accepted
- Jul 26, 4:30 PM ET
- Size
- 6.6 KB